Tag - David Gill

Richard Kollender Strongbridge Biopharma (NASDAQ:SBBP) named Richard Kollender as COO, promoted Robert Lutz to CFO and appointed David Gill to its board, effective Sept. 3. “Continuing to assemble an experienced, multi...